Kirr Marbach & Co. LLC IN Has $4.39 Million Stock Position in RXO, Inc. (NYSE:RXO)

Kirr Marbach & Co. LLC IN trimmed its position in RXO, Inc. (NYSE:RXO) by 1.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 188,922 shares of the company’s stock after selling 2,793 shares during the quarter. Kirr Marbach & Co. LLC IN owned approximately 0.16% of RXO worth $4,394,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Douglas Lane & Associates LLC increased its position in RXO by 10.7% in the fourth quarter. Douglas Lane & Associates LLC now owns 2,579,390 shares of the company’s stock worth $59,997,000 after purchasing an additional 248,883 shares during the period. Nisa Investment Advisors LLC grew its position in shares of RXO by 65.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 6,863 shares of the company’s stock worth $135,000 after buying an additional 2,718 shares during the period. Barclays PLC grew its position in shares of RXO by 299.9% during the 3rd quarter. Barclays PLC now owns 270,766 shares of the company’s stock worth $5,343,000 after buying an additional 203,052 shares during the period. GSA Capital Partners LLP grew its position in shares of RXO by 325.2% during the 3rd quarter. GSA Capital Partners LLP now owns 55,077 shares of the company’s stock worth $1,087,000 after buying an additional 42,123 shares during the period. Finally, Motley Fool Asset Management LLC grew its position in shares of RXO by 151.5% during the 3rd quarter. Motley Fool Asset Management LLC now owns 403,658 shares of the company’s stock worth $7,964,000 after buying an additional 243,137 shares during the period. 92.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on RXO shares. Susquehanna boosted their target price on RXO from $15.00 to $16.00 and gave the stock a “negative” rating in a research report on Monday, March 25th. Vertical Research lowered RXO from a “buy” rating to a “hold” rating and set a $23.00 target price for the company. in a research report on Wednesday, January 10th. Bank of America cut RXO from a “buy” rating to a “neutral” rating and cut their price objective for the company from $25.00 to $22.00 in a report on Thursday, February 8th. Stifel Nicolaus lifted their price objective on RXO from $20.00 to $22.00 and gave the company a “hold” rating in a report on Wednesday, January 10th. Finally, Oppenheimer cut their price objective on RXO from $23.00 to $22.00 and set an “outperform” rating on the stock in a report on Tuesday, February 13th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $20.23.

Insiders Place Their Bets

In related news, major shareholder Mfn Partners, Lp purchased 919,720 shares of the stock in a transaction on Thursday, February 8th. The shares were purchased at an average price of $21.04 per share, with a total value of $19,350,908.80. Following the transaction, the insider now directly owns 14,675,369 shares of the company’s stock, valued at $308,769,763.76. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 1.50% of the company’s stock.

RXO Stock Up 0.5 %

NYSE RXO traded up $0.10 during trading on Tuesday, hitting $20.35. The stock had a trading volume of 92,690 shares, compared to its average volume of 623,613. The company has a market capitalization of $2.39 billion, a PE ratio of 506.13, a P/E/G ratio of 7.25 and a beta of 1.08. The company’s 50-day moving average price is $21.10 and its two-hundred day moving average price is $20.87. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.17 and a current ratio of 1.17. RXO, Inc. has a 12 month low of $16.94 and a 12 month high of $24.33.

RXO (NYSE:RXO) last released its earnings results on Thursday, February 8th. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.03 by $0.03. The firm had revenue of $978.00 million for the quarter, compared to analysts’ expectations of $996.33 million. RXO had a return on equity of 6.11% and a net margin of 0.10%. The business’s quarterly revenue was down 12.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.28 EPS. As a group, sell-side analysts forecast that RXO, Inc. will post 0.22 EPS for the current year.

RXO Profile

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.